UnitedHealth Group Incorporated reported that it issued its second-quarter 2026 earnings release on July 16, 2026, announcing the company’s results of operations and financial condition for the period. The Form 8-K was filed the same day under Item 2.02, “Results of Operations and Financial Condition.” The filing states that UnitedHealth furnished a press release dated July 16, 2026, as Exhibit 99.1. The press release also included a hyperlink to a PDF document, which the company furnished separately as Exhibit 99.2. Both exhibits are incorporated by reference into the Item 2.02 disclosure, but the filing text provided does not include the actual financial figures, such as revenue, earnings, margins, cash flow, medical cost ratios, guidance, or segment-level performance. There is no reported insider trading, stock purchase, equity award, option exercise, share sale, merger, financing transaction, management change, or securities issuance in the document. No share counts, transaction prices, ownership totals, vesting schedules, or transaction codes are disclosed because this is an earnings-results Form 8-K rather than a Form 4 or transactional filing. UnitedHealth also included the standard Item 9.01 exhibit listing, identifying the July 16 press release, the related hyperlinked PDF, and the cover page interactive data file. The company noted that the Item 2.02 information is being “furnished” rather than “filed” for purposes of Section 18 of the Securities Exchange Act, meaning it is provided to inform investors but is not automatically incorporated into other securities filings unless specifically referenced. The report was signed by Kuai H. Leong, Senior Deputy General Counsel and Deputy Corporate Secretary.